Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Aizawa K, Kawasaki R, Tashiro Y, Shimonaka Y, Hirata M. Epoetin beta pegol for treatment of anemia ameliorates deterioration of erythrocyte quality associated with chronic kidney disease. BMC Nephrol 2018;19:19. [PMID: 29374477 PMCID: PMC5787256 DOI: 10.1186/s12882-018-0818-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2017] [Accepted: 01/17/2018] [Indexed: 11/26/2022] Open

For:	Aizawa K, Kawasaki R, Tashiro Y, Shimonaka Y, Hirata M. Epoetin beta pegol for treatment of anemia ameliorates deterioration of erythrocyte quality associated with chronic kidney disease. BMC Nephrol 2018;19:19. [PMID: 29374477 PMCID: PMC5787256 DOI: 10.1186/s12882-018-0818-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2017] [Accepted: 01/17/2018] [Indexed: 11/26/2022] Open

Number	Cited by Other Article(s)
1	Early responsiveness to continuous erythropoietin receptor activator predicts renal prognosis and is determined by a novel antioxidative marker in non-dialysis chronic kidney disease: a prospective, observational, single-center study. Clin Exp Nephrol 2020;24:590-597. [DOI: 10.1007/s10157-020-01873-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2019] [Accepted: 03/04/2020] [Indexed: 10/24/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Early responsiveness to continuous erythropoietin receptor activator predicts renal prognosis and is determined by a novel antioxidative marker in non-dialysis chronic kidney disease: a prospective, observational, single-center study. Clin Exp Nephrol 2020;24:590-597. [DOI: 10.1007/s10157-020-01873-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2019] [Accepted: 03/04/2020] [Indexed: 10/24/2022]